With the deprivation of both circulating androgen (CA) and luminal androgen (LA; orchiectomized goats), the epithelial height (EH) in regions I–IV of the epididymis was reduced to 28, 67, 58 and 56% of that of controls, respectively, but it was increased to 109% of that of controls in region V. Similarly, the volume density of epithelium (VDE) in regions I–V was reduced to 33, 49, 45, 41 and 70% of that of controls, respectively. Conversely, in the absence of LA only (extratesticular-rete-ligated goats), while both EH and VDE were reduced to almost 50% of those of controls in region I, they remained similar to those of controls in other regions. The morphological changes in the epithelium such as cytoplasmic regression, loss of stereocilia and disorderly arrangement of epithelial cells were maximal in region I, moderate in regions II–IV and minimal in region V. Testosterone treatment appreciably reduced the degenerative changes caused by orchiectomy in all regions except region I where the restorations were marginal at best. Hence, the results suggest a differential epididymal response to androgen deprivation. Whereas the LA and/or other rete fluid components seem essential for maintaining the epithelial structure of region I, the CA alone can maintain, at least partially, the epithelial structure of regions II–IV and almost completely that of region V.

Keywords:
Epididymis, Androgen, Goat
This content is only available via PDF.
© 1994 S. Karger AG, Basel
1994
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.